Similar articles

• Monoamine oxidase inhibitors and subarachnoid hemorrhage.

  Kundhal PS, Sockalingam S, Krishnadev N, Demarchi R, Bhalerao S. Kundhal PS, et al. Can J Psychiatry. 2004 Aug;49(8):573-4. doi: 10.1177/070674370404900813. Can J Psychiatry. 2004. PMID: 15453109 No abstract available.
• Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome.

  Rim CL, Gitlin MJ. Rim CL, et al. J Clin Psychopharmacol. 2010 Aug;30(4):470-1. doi: 10.1097/JCP.0b013e3181e63033. J Clin Psychopharmacol. 2010. PMID: 20631570 No abstract available.
• Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.

  Tulen JH, Volkers AC, van den Broek WW, Bruijn JA. Tulen JH, et al. J Clin Psychopharmacol. 2006 Oct;26(5):542-4. doi: 10.1097/01.jcp.0000236657.08663.ae. J Clin Psychopharmacol. 2006. PMID: 16974207 Clinical Trial. No abstract available.
• 'Spontaneous' hypertensive episodes with monoamine oxidase inhibitors.

  Fallon B, Foote B, Walsh BT, Roose SP. Fallon B, et al. J Clin Psychiatry. 1988 Apr;49(4):163-5. J Clin Psychiatry. 1988. PMID: 3281932 Review.
• [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].

  Volz HP, Gleiter CH, Möller HJ. Volz HP, et al. Nervenarzt. 1996 May;67(5):339-47. Nervenarzt. 1996. PMID: 9005342 Review. German.